← Leaderboards
Masakazu Kamata
University Of California Los Angeles
$5,573,549
Attributed
$5,573,549
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $936.6K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,573,549 · 4
By mechanism
R01$5,165,174 · 3
R21$408,375 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Jing Wen$2,923,926
- Harold George Monbouquette$4,165,441
- Leonard H Rome$6,992,522
- Irvin S.y. Chen$31,294,828
- Gerald S Lipshutz$7,859,338
Others in their field
Top investigators on “Novel Strategies”
- Judith S. Currier · University Of California Los Angeles$321,300,358
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$303,952,589
- Richard A Gibbs · Baylor College Of Medicine$295,698,028
- Constance Ann Benson · University Of California, San Diego$278,253,569
- Dennis R. Burton · Scripps Research Institute$256,423,824
Research focus
Novel StrategiesCellsIn VivoMouse ModelPropertyResponseImmune ResponseHumanized MouseLocationBrainAntibodiesPenetrationPharmaceutical PreparationsMaintenanceNanocapsuleBaseSignal TransductionAnti-CancerAffinityMalignant NeoplasmsMonoclonal AntibodiesGenesEnsureBlood - Brain Barrier Anatomy
Grant awards (14)
The resurgence of antibody-drug conjugates via PMPC-polymer engineering$585,228
R01 · FY2025 · CA · contact PI
The resurgence of antibody-drug conjugates via PMPC-polymer engineering$585,228
R01 · FY2024 · CA · contact PI
Eradication of brain/CNS HIV reservoirs via anti-HIV gene-modified macrophages$185,625
R21 · FY2023 · MH · contact PI
Nanodelivery platform for antibody drugs targeting NHL$452,835
R01 · FY2022 · CA · contact PI
Eradication of brain/CNS HIV reservoirs via anti-HIV gene-modified macrophages$222,750
R21 · FY2022 · MH · contact PI
Nanodelivery platform for antibody drugs targeting NHL$463,906
R01 · FY2021 · CA · contact PI
Nanodelivery platform for antibody drugs targeting NHL$489,135
R01 · FY2020 · CA · contact PI
Nanodelivery platform for antibody drugs targeting NHL$497,264
R01 · FY2019 · CA · contact PI
Gene-Engineered Stem Cell Memory T-Cells With Anti-HIV Chimeric Antigen Receptors$327,432
R01 · FY2019 · AI · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$57,568
R01 · FY2019 · AI · contact PI
Nanodelivery platform for antibody drugs targeting NHL$551,578
R01 · FY2018 · CA · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$385,000
R01 · FY2018 · AI · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$385,000
R01 · FY2017 · AI · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$385,000
R01 · FY2016 · AI · contact PI